Profile of:
Rik Lories
Rik Lories is Full Professor at KU Leuven. He is the Chair of the Department of Development and Director of the Skeletal Biology and Engineering Research Center that includes the Laboratory for Tissue Homeostasis and Disease that he is leading together with Prof. Silvia Monteagudo. He is the Chair of the Division of Rheumatology at the University Hospitals Leuven. His research focuses on endogenous tissue responses in the joint with specific attention towards translational questions in chronic arthritis, in particular osteoarthritis, axial spondyloarthritis, and psoriatic arthritis. He obtained his medical degree summa cum laude in 1996. In 2003, he was certified as rheumatologist. In 2003 he also obtained a PhD in biomedical sciences at KU Leuven. He is board member of the Osteoarthritis Research Society International (OARSI), of the Royal Belgian Society of Rheumatology and Scientific Chair of the Rheumatology Research Fund Belgium. Currently, he serves as associate editor for the journals Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage. He has (co-)authored > 160 publications, including original research reports or reviews in Nature Medicine, Science Translational Medicine, Nature Communications, Journal of Clinical Investigation, PNAS, Nature Reviews Rheumatology and Annals of the Rheumatic Diseases.
Full name: Rik Lories
Current country: Belgium
Membership level: Full
Type of membership: Member
Number of publications: 12
Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts. (2023)
https://pubmed.ncbi.nlm.nih.gov/37137541/
Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study. (2022)
https://pubmed.ncbi.nlm.nih.gov/34977986/
Cellular and molecular diversity in spondyloarthritis. (2021)
https://pubmed.ncbi.nlm.nih.gov/34763975/
Potential insights into the role of biomechanical stress in axial spondyloarthritis from idiopathic hypoparathyroidism, a rare disease with intriguing skeletal manifestations (2021)
https://pubmed.ncbi.nlm.nih.gov/34665705/
Impact of barrier tissue inflammation and physical activity on joint homeostasis in mice. (2021)
https://pubmed.ncbi.nlm.nih.gov/34175921/
Tenascin-C, a novel target to inhibit new bone formation in axial spondyloarthritis, linked with inflammation, mechanical strain and tissue damage. (2021)
https://pubmed.ncbi.nlm.nih.gov/33990317/
Tenascin-C, a novel target to inhibit new bone formation in axial spondyloarthritis, linked with inflammation, mechanical strain and tissue damage. (2021)
https://pubmed.ncbi.nlm.nih.gov/33990317/
Ankylosing spondylitis: an autoimmune or autoinflammatory disease? (2021)
https://pubmed.ncbi.nlm.nih.gov/34113018/
Inflammasome Activation in Ankylosing Spondylitis Is Associated With Gut Dysbiosis (2021)
https://pubmed.ncbi.nlm.nih.gov/33452867/
Changes in bone formation regulator biomarkers in early axial spondyloarthritis. (2021)
https://pubmed.ncbi.nlm.nih.gov/32888036/
Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatment (2021)
https://pubmed.ncbi.nlm.nih.gov/33326852/
To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33547227/
